Compare Edwards Lifesciences Corporation Common Stock (EW) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Invesco NASDAQ 100 ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Invesco NASDAQ 100 ETF trades at $310.55 (market cap $113.42B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 2.3× Edwards Lifesciences Corporation Common Stock's market cap, and Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | QQQM | |
|---|---|---|
Market Cap | $49.44B | $113.42B |
Volume | 3,508,027 | 2,896,306 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $312.76 |
52-Week Low | $72.65 | $229.87 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 54 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQM trades at $312.01, down 0.24% on the day, with a bullish technical outlook supported by moving averages but showing overbought conditions on shorter-term RSI readings. The ETF maintains its focus on Nasdaq-100 exposure with a competitive 0.15% expense ratio. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% during Q2 2026 according to SEC filings.
The ETF's outlook remains positive given Nasdaq-100 strength, though investors face concentration risk in technology stocks and potential volatility from overbought conditions. The lower expense ratio provides cost advantage over competitors, but trading spreads and tax implications of distributions require careful consideration for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
